The pharmaceutical industry operates under strict environmental, safety, and quality regulations. Yet, one aspect that often remains under-discussed is the complexity of emission treatment in pharma plants – where volatile organic compounds (VOCs), solvents, acids, and other hazardous pollutants can challenge even the most advanced air abatement systems.

In this article, we explore the main types of emissions, the most suitable technologies for their treatment, and the hidden risks that may compromise both environmental performance and operational reliability.

 

  1. Understanding Emission Types in the Pharmaceutical Sector

Pharmaceutical processes are diverse — from synthesis and formulation to packaging — and each stage can generate emissions with very different compositions. The most common types of emissions include:

  • Volatile Organic Compounds (VOCs) from solvent evaporation, cleaning, and drying operations.
  • Acidic gases such as HCl, HF, or SOx resulting from chemical reactions.
  • Particulate matter and aerosols, often containing active pharmaceutical ingredients (APIs).
  • Odorous compounds that, while not always toxic, can cause nuisance and regulatory non-compliance.

A correct characterization of emission streams is essential before selecting the abatement technology. Even small variations in concentration, humidity, or temperature can significantly affect system performance.

 

  1. Proven Emission Treatment Technologies

At Tecam, we have engineered and installed emission treatment systems for numerous pharmaceutical plants worldwide. Based on this experience, the most efficient and reliable technologies include:

 

Regenerative Thermal Oxidation Systems and Catalytic (RTO, RCO)

Thermal Oxidizers are ideal for VOC destruction with efficiencies above 99%.

 

Wet Scrubbers

Wet Gas Scrubbers are effective for acidic gases and particulate matter. Can be combined with oxidation systems in multi-stage configurations to achieve comprehensive treatment.

 

Activated Carbon Filters

Activated carbon filters are useful as a polishing step or for low-concentration VOC removal. They require careful management to avoid saturation and secondary emissions.

Selecting the right combination of technologies – and designing them according to flow rate, concentration, and chemical composition — is key to ensuring both regulatory compliance and energy efficiency.

 

  1. Hidden Risks in Pharma Emission Control

Despite rigorous control systems, several hidden risks can compromise performance and safety:

  • Condensation and clogging: High humidity and low temperatures can cause solvent condensation, damaging oxidation systems or clogging ducts.
  • Incompatible materials: Corrosive gases may attack internal components if materials are not properly selected.
  • Incomplete combustion or oxidation: Poor temperature or residence time control may lead to unburned compounds and non-compliance.
  • Neglected maintenance: Even minor leaks or faulty seals can result in emissions and energy losses.

A preventive maintenance plan and continuous monitoring are critical to avoid these pitfalls.

 

  1. Towards Sustainable and Compliant Pharma Operations

As pharmaceutical companies advance toward sustainability and carbon reduction goals, emission treatment is no longer a regulatory obligation — it is a strategic element of environmental performance.

Modern systems are designed not only to destroy pollutants but also to recover energy and minimize operational costs.

 

At Tecam, we partner with pharmaceutical manufacturers worldwide to design and instal tailor-made emissions treatment solutions that ensure compliance, efficiency, and long-term reliability.

Contact us today to learn how we at Tecam can help you with your emissions issues at your pharma production plant.